ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
go to the article

go back to the homepage

  • Subscription
  • Newsletter
  • Advertise
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Corporate publications
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ADVERTISEMENT

SPONSORED PUBLICATIONS

DROOMS - Whitepaper

14 Must-Haves to Boost the Efficiency of Your Data Room

Stop wasting time with data room software that doesn’t really improve your workflow. more ➔

The Jackson Laboratory

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies. more ➔

ADVERTISEMENT

RightsDirect

TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

How Content Access and Manual Process Hinder Mining Efforts more ➔

placeholder

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Page 24 of 24«‹222324

LATEST NEWS

Photo of Roche Tower by Basil Minhaj via Unsplash+

Roche bets up to $813M on Zymeworks lung cancer can...

The Leadership Edit Thumbnail European Biotechnology

Sensorion names CMO; Orano Med adds CSO; CRISPR The...

scrap paper

Roche scraps off-the-shelf CAR-T from Poseida deal...

ADVERTISEMENT

MAGAZINE

1 / 4
EBM 3.2026 Autumn_cover

The autumn issue of European Biotechnology magazine asks what happens when biotech leaves Earth. Our cover story explores how microgravity could help researchers study disease, improve drug formulations … more ➔

2 / 4

The summer issue of European Biotechnology Magazine showcases the latest developments in drug delivery and RNA technologies. This issue features a list of eight venture capital firms to watch in 2026. … more ➔

3 / 4

The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can … more ➔

4 / 4
EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

SPONSORED PUBLICATION

1 / 3
Team Invitris
artificial intelligence

Closing AI medicine’s manufacturing gap

At the IZB in Martinsried, Invitris is developing a cell-free platform to turn ­digital sequences into proteins, antibodies and phages within hours. CEO Patrick Grossmann explains why AI is shifting … more ➔

2 / 3
IDT Biologika
CRO & CDMO

From development to commercial reality

Helping biopharmaceutical innovators build scalable, manufacturable, and commercially viable processes from the start. more ➔

3 / 3
Professor Jacob George, Chief Medical and Scientific Officer at the MHRA presenting his keynote speech at Phacilitate Advanced Therapies Europe, 2026
Cell & Gene Therapy

Europe’s CGT advantage at risk

Industry leaders at Advanced Therapies Europe 2026 warned that Europe must tackle barriers across commercialisation, regulation, reimbursement, manufacturing and patient access to retain its global … more ➔

newsletter_link
Knowbio GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top